These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37829519)

  • 1. Retracted: Effect and Mechanism of lncRNA CERS6-AS1 on the Biological Behavior of Prostate Cancer Cell.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9759358. PubMed ID: 37829519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect and Mechanism of lncRNA CERS6-AS1 on the Biological Behavior of Prostate Cancer Cell.
    Huang F; Zhou LQ
    Appl Bionics Biomech; 2022; 2022():9292538. PubMed ID: 35706508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lncRNA CERS6-AS1 in cancer and its molecular mechanisms: A systematic review and meta-analysis.
    Rastad H; Samimisedeh P; Alan MS; Afshar EJ; Ghalami J; Hashemnejad M; Alan MS
    Pathol Res Pract; 2023 Jan; 241():154245. PubMed ID: 36580796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA CERS6-AS1 plays a prognostic role in promoting the progression of gastric cancer.
    Li Z; Liu X; Luo N; Pang Y; Hou Y; Jiang G
    Bioengineered; 2021 Dec; 12(2):12931-12939. PubMed ID: 34852705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression.
    Yan L; Li K; Feng Z; Zhang Y; Han R; Ma J; Zhang J; Wu X; Liu H; Jiang Y; Zhang Y; Zhu Y
    Mol Carcinog; 2020 Oct; 59(10):1199-1208. PubMed ID: 32808708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CERS6-AS1 Is a Tumor Promoter in Cervical Cancer by Sponging miR-195-5p.
    Xiong S; Song H
    Ann Clin Lab Sci; 2023 Jan; 53(1):30-41. PubMed ID: 36889776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CERS6-AS1 Facilitates Oncogenesis and Restrains Ferroptosis in Papillary Thyroid Carcinoma by Serving as a ceRNA through miR-497-5p/LASP1 Axis.
    Huang T; Guan S; Wang C
    Ann Clin Lab Sci; 2022 May; 52(3):426-438. PubMed ID: 35777805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CERS6-AS1 contributes to the malignant phenotypes of colorectal cancer cells by interacting with miR-15b-5p to regulate SPTBN2.
    Zhao SY; Wang Z; Wu XB; Zhang S; Chen Q; Wang DD; Tan QF
    Kaohsiung J Med Sci; 2022 May; 38(5):403-414. PubMed ID: 35146902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2.
    Yan K; Hu C; Liu C; Chu G; Wang X; Ma S; Li L
    Histol Histopathol; 2023 Jul; 38(7):823-835. PubMed ID: 36444938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CERS6-AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR-195-5p/WIPI2 axis.
    Gao KF; Zhao YF; Liao WJ; Xu GL; Zhang JD
    Kaohsiung J Med Sci; 2022 Jun; 38(6):542-553. PubMed ID: 35199935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C.
    Pan W; Chen KJ; Huang YC
    Anticancer Drugs; 2022 Oct; 33(9):913-922. PubMed ID: 36136991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA CERS6-AS1 modulates glucose metabolism and tumor progression in hepatocellular carcinoma by promoting the MDM2/p53 signaling pathway.
    Xu B; Wei Y; Liu F; Li L; Zhou S; Peng Y; Li B
    Cell Death Discov; 2022 Aug; 8(1):348. PubMed ID: 35927226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CERS6 antisense RNA 1 promotes colon cancer via upregulating mitochondrial calcium uniporter.
    Yu J; Chen X; Li J; Wang F
    Eur J Clin Invest; 2023 May; 53(5):e13951. PubMed ID: 36628448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2BP3 Worsens Lung Cancer through Modifying Long Non-coding RNA CERS6-AS1/microRNA-1202 Axis.
    Yan A; Song X; Liu B; Zhu K
    Curr Med Chem; 2023; 30(7):878-891. PubMed ID: 35702784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC-activated CERS6-AS1 sponges miR-6838-5p and regulates the expression of RUBCNL in colorectal cancer.
    Chen D; You H; Xu X; Liu D; Shen M; Pan Y; Liu Z; Zhang L; Wang H
    Cell Mol Biol (Noisy-le-grand); 2022 Dec; 68(12):42-48. PubMed ID: 37130182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: LncRNA SBF2-AS1 Facilitates Nonsmall Cell Lung Cancer Progression by Targeting miR-520a-3p.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9763427. PubMed ID: 37593490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA CERS6-AS1 Accelerates the Proliferation and Migration of Pancreatic Cancer Cells by Sequestering MicroRNA-15a-5p and MicroRNA-6838-5p and Modulating HMGA1.
    Shen R; Wang X; Wang S; Zhu D; Li M
    Pancreas; 2021 Apr; 50(4):617-624. PubMed ID: 33939677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: lncRNA FOXD2-AS1 Promotes the Retinoblastoma Cell Viability and Migration by Sponging miR-31.
    International BR
    Biomed Res Int; 2023; 2023():9802968. PubMed ID: 37539018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9854591. PubMed ID: 37811245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9782478. PubMed ID: 37829632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.